BEDFORD, Ohio, January 03, 2008 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories Inc., announced the acquisition of CAFCIT(R) (caffeine citrate) Injection and CAFCIT(R) (caffeine citrate) Oral Solution from Mead Johnson & Company. Bedford Laboratories is now the reference listed drug holder. CAFCIT(R) (caffeine citrate) is indicated for the short term treatment of apnea in premature infants between 28 and <33 weeks gestational age.
"The acquisition of CAFCIT(R) demonstrates our continued commitment to build the most comprehensive and cost effective line of injectable products in the pharmaceutical industry. We are proud to offer a branded product at a generic price," said David Gaugh, Vice President and General Manager of Bedford Laboratories.
Bedford Laboratories will supply latex free CAFCIT(R) (caffeine citrate) Injection and CAFCIT(R) (caffeine citrate) Oral Solution as a sterile liquid in the following presentations:
-- Injection: 60 mg/3 mL single-use vials individually boxed
-- Oral Solution: 60 mg/3 mL single-use vials, 10 vials per child-resistant container
Sunday, January 6, 2008
Bedford Laboratories Announces the Acquisition of Cafcit (Caffeine Citrate) Injection Cafcit (Caffeine Citrate) Oral Solution
Posted by Amit at 7:19 PM
Subscribe to:
Post Comments (Atom)
2 comments:
where can i buy this medicine...im living in australia now.
i need this medicine for my sister's baby.
if u can tell me where it is available..in india or australia..that will be really appriciated.
thanks,
sai
sai_crish@yahoo.com
Caffeine citrate as injection is available in Australia. The Manufacturers address is as follows:
Phebra Pty Ltd
332 Burns Bay Road,
Lane Cove NSW 2066,
Australia
Try and contact at this address. These people can help you.
Post a Comment